Wolf Popper LLP
Wolf Popper Files Securities Fraud Class Action Against Transkaryotic Therapies, Inc.
Wolf Popper LLP has filed a securities fraud lawsuit against Transkaryotic Therapies, Inc. (“TKT”) (NASD:TKTX), in the United States District Court for the District of Massachusetts, on behalf of persons who purchased TKT securities, or who sold put options, on the open market from January 4, 2001 through January 14, 2003.
